Events Search and Views Navigation
April 2020
Live Webinar: GARDP/REVIVE – Inhaled antimicrobials: Do we get the drug to the bug?
Speaker: Harm A. W. M. Tiddens, Professor of Pediatric Pulmonology and Allergology, Erasmus Medical Center Sophia Children’s Hospital (Netherlands) Moderator: Harpal Singh Dhillon, Global Medical Value Director & Founder, AntiBx (UK) In this webinar, Harm Tiddens will discuss the relation between structural and functional abnormalities of the lung and how this can impact upon the deposition pattern and efficacy of inhaled antibiotics. He will further present the learnings of his research group’s computational fluid dynamic modelling studies and explain why the expectation that inhaled…
Find out more »May 2020
Live Webinar: GARDP/REVIVE – The challenges and opportunities for antimicrobial R&D in low- and middle-income countries – India case study
Speakers: Anand Anandkumar, Co-founder and CEO Bugworks Research Inc (India) Kamini Walia, Program Officer, ICMR-AMR Initiative (India) Moderator: François Franceschi, GARDP In this webinar, Anand Anandkumar and Kamini Walia will discuss: Why is India one of the hotbeds of the AMR problem? Latest statistics of growing drug resistance etc. Initiatives of the Indian Government to curb the AMR problem Antimicrobial R&D landscape in India – a vibrant ecosystem supporting innovation in AMR diagnosis, prevention and therapeutics Fledgling antimicrobial clinical trial networks – could trials…
Find out more »Live Webinar: GARDP/REVIVE – Probability of target attainment analyses for dose selection in antimicrobial drug development
Speaker: Shampa Das, Senior Lecturer, Centre of Excellence in Infectious Diseases Research, University of Liverpool (UK) Moderator: Vincent H. Tam, Professor, University of Houston (US) In this webinar, Shampa Das will give an overview of her work in studying the PK/PD and probability of target attainment for dose selection. Topics discussed will include: An overview of what is meant by the probability of target attainment (PTA) How it is calculated and what data is used for this How PTA is used for decision making…
Find out more »June 2020
Live Webinar: GARDP/REVIVE – Test tube to patient: PK/PD of fixed dose beta-lactam/beta-lactamase inhibitor combinations
Speaker: Vincent H. Tam, Professor, University of Houston College of Pharmacy (USA) Moderator: Shampa Das, Senior Lecturer, Centre of Excellence in Infectious Diseases Research, University of Liverpool (UK) In this webinar, Vincent H. Tam will present on his work looking at studying PK/PD in fixed dose beta-lactam/beta-lactamase inhibitor (BL/BLI) combinations. Topics discussed will include: Understanding the inherent challenges associated with PK/PD of BL/BLI combinations Demonstrating new approaches to gain useful insights from preclinical PK/PD models The presentation will be followed by a Q&A…
Find out more »August 2020
BIOCOM 4th AMR Conference: Novel Antimicrobials and AMR Diagnostics
Conference rescheduled from March 2020 due to coronavirus, additional details to follow. Speakers include Kevin Outterson, Executive Director of CARB-X, and Karen Gallant, Deputy Executive Director. This conference is a platform to discuss strategies and the specific challenges faced by SMEs in bringing new antimicrobial treatments and diagnostics to market. The #AMRconference is a platform for SMEs, start-ups, big pharma, academia, investors and public institutions to discuss strategies and the specific challenges faced by SMEs in bringing new…
Find out more »